Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | GGT1 | P19440 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31113422 | 1.00 | HSD17B10 (0.54) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL1193101 | 0.86 | KDM4E (0.49) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL9516082 | 0.82 | SMN1; SMN2 (0.52) | HSD17B10KDM4ELMNASMN1; SMN2TSHR | |
| SCHEMBL31113429 | 0.82 | SMN1; SMN2 (0.52) | HSD17B10KDM4ELMNASMN1; SMN2TSHR | |
| SCHEMBL1845901 | 0.81 | SMN1; SMN2 (0.55) | HSD17B10KDM4ELMNASMN1; SMN2ALDH1A1 | |
| Aspirin SCHEMBL9426063 | 0.78 | KDM4E (0.61) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL9721396 | 0.77 | SMN1; SMN2 (0.63) | KDM4ELMNASMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL21449134 | 0.73 | PTGS2 (0.68) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL27969404 | 0.72 | HSD17B10 (0.67) | HSD17B10KDM4ELMNACYP1A2CYP2C9 | |
| SCHEMBL5988737 | 0.71 | HSD17B10 (0.71) | HSD17B10KDM4ELMNACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| US-20120328696-A1 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | HUTECS KOREA PHARMACEUTICAL CO., LTD. (KR) | 2012-12-27 | — | — | US | claimed |
| US-20110039807-A1 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | HUTECS KOREA PHARMACEUTICAL CO. LTD (KR) | 2011-02-17 | — | — | US | claimed |
| WO-2010020920-A2 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | KANGWON NATIONAL UNIVERSITY (KR) | 2010-02-25 | — | — | WO | claimed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| CN-119833201-A | Conductive silver paste, method for preparing back electrode of solar cell and solar cell | 乐凯胶片股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| US-11645676-B2 | Extending audience reach in messaging campaigns using probabilistic ID linking | ORACLE INTERNATIONAL CORPORATION (US) | 2023-05-09 | — | — | US | disclosed |
| US-20120328696-A1 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | HUTECS KOREA PHARMACEUTICAL CO., LTD. (KR) | 2012-12-27 | — | — | US | disclosed |
| WO-2010020920-A3 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | KANGWON NATIONAL UNIVERSITY (KR) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010020920-A2 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | KANGWON NATIONAL UNIVERSITY (KR) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010020920-A2 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | KANGWON NATIONAL UNIVERSITY (KR) | 2010-02-25 | — | — | WO | disclosed |
| WO-2010020920-A2 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | KANGWON NATIONAL UNIVERSITY (KR) | 2010-02-25 | — | — | WO | disclosed |
| EP-0544681-B1 | A NOVEL SALICYLIC ACID-MALTOL CONJUGATES | HAN BYUNG HOON (KR) | 1997-02-12 | — | — | EP | disclosed |
| US-5349070-A | Side effect reduction of ulcers; antioxidants, anticoagulants | HAN BYUNG H (KR) | 1994-09-20 | — | — | US | disclosed |
| EP-0544681-A1 | A NOVEL SALICYLIC ACID-MALTOL CONJUGATES. | HAN BYUNG HOON (KR) | 1993-06-09 | — | — | EP | disclosed |
| WO-1993000339-A1 | A NOVEL SALICYLIC ACID-MALTOL CONJUGATES | HAN BYUNG HOON (KR) | 1993-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039807-A1 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | SNCA, PARK7, MGAM | HSD17B10 1296/4885KDM4E 3957/4885LMNA 3806/4885 |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | HSD17B10 1696/4885KDM4E 4332/4885LMNA 2204/4885 |
| US-20120328696-A1 | ANTI-PARKINSONIAN COMPOUND ACETYLSALICYLIC ACID MALTOL ESTER | SNCA, PARK7, MGAM | HSD17B10 1296/4885KDM4E 3957/4885LMNA 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.